Cameco Corporation (NYSE:CCJ) does about 4.68M shares in volume on a normal day but saw 3548500 shares change hands in Monday trading. The company now has a market cap of 11.17B USD. Its current market price is $26.87, marking an increase of 2.17% compared to the previous close of $26.30. The 52 week high reached by this stock is $32.49 whilst the lowest price level in 52 weeks is $18.03. The script in recent trading has seen the stock touch a high of $26.87 and a low of $26.11.
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
Sponsored
Cameco Corporation (CCJ) has a 20-day trading average at $24.15 and the current price is -17.30% off the 52-week high compared with 49.03% distance from its 52-week low. The 50-day simple moving average of the closing price is $23.48 and its 200-day simple moving average is $24.73. If we look at the stock’s price movements over the week, volatility stands at 3.73%, which decreases to 3.10% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 71.85 to suggest the stock is overbought.
The consensus objective for the share price is $33.60, suggesting that the stock has a potential upside of 20.03% over the period.
BofA Securities upgraded its price target at $32.
The current price level is 12.38%, 14.69%, and 8.63% away from its SMA20, SMA50, and SMA200 respectively, with the CCJ price moving above the 50-day SMA on January 23. Cameco Corporation (CCJ) stock is up 5.41% over the week and 23.43% over the past month. Its price is 18.53% year-to-date and 25.56% over the past year.
CCJ’s earnings per share are forecast to grow by 220.00% this year and 258.30% over next year. Expected sales for next quarter are $421.21 million, which analysts say will come at $1.36 billion for the current fiscal year and next year at $1.83 billion. In addition, estimates put the company’s current quarterly revenue at an average of $358.48 million.
To reach the target analysts have set, the stock logically needs to grow 20.03 percent from here.
Outstanding shares total 432.50M with insiders holding 0.12% of the shares and institutional holders owning 67.52% of the company’s common stock. The company has a return on investment of -1.90% and return on equity of 2.40%. The price to earnings ratio (P/E ratio) amounts to 124.98 while the forward price to earnings ratio is 32.81. The beta has a value of 0.90. Price to book ratio is 2.95 and price to sales ratio is 8.31.
Global X Uranium ETF isn’t the only investment manager who changed stakes and is followed by American Funds Capital World Grow, which added 2.68 million shares to end up with 11,446,000 shares worth $259.48 million. T Rowe Price Mid Cap Value Fund cut their holdings by -19.23% in the company over the course of the most recent quarter. It now holds a 1.35% position in Cameco Corporation thanks to 5.84 million shares amounting to $132.28 million.
